MacroGenics to Participate in the Stifel 2025 Healthcare Conference
MacroGenics to Participate in the Stifel 2025 Healthcare Conference GlobeNewswire November 06, 2025 ROCKVILLE, MD, Nov. 06, 2025 (GLOBE NEWSWIRE) — MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing innovative antibody-based therapeutics for the treatment of cancer, today announced that Eric Risser, President and CEO of MacroGenics, will participate in a fireside chat […]